RBC Capital raises Gilead Sciences (NASDAQ:GILD) price target from $83 to $84

By / / Gilead Sciences, Royal Bank of Canada

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and raises the price target from $83 to $84.

Scroll to Top